Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy
Open Access
- 8 June 2006
- journal article
- Published by Wiley in BJU International
- Vol. 98 (1) , 67-69
Abstract
OBJECTIVE: To estimate the rate of relapse in men with stage I nonseminomatous germ cell tumours (NSGCT) of the testis treated with one cycle of chemotherapy instead of the usual two cycles. PATIENTS AND METHODS: Between 1992 and 1996, 22 men with stage I NSGCT who had normalized tumour markers after orchidectomy and negative findings on computed tomography, and who were at moderate risk of relapse, were treated with one cycle of platinum‐containing chemotherapy (bleomycin and etoposide with either cisplatin or carboplatin). RESULTS: At a median follow‐up of 10.2 years, none of the patients have relapsed with malignant GCTs. CONCLUSIONS: The results after one cycle of chemotherapy are no worse than after two cycles. The present study needs to be replicated in a larger cohort of patients to define the relapse risk more accurately. This approach is soon to be tested in a large multicentre trial randomizing patients between one and two cyclesKeywords
This publication has 9 references indexed in Scilit:
- Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trialThe Lancet, 2005
- Predictors of Occult Metastasis in Clinical Stage I Nonseminoma: A Systematic ReviewJournal of Clinical Oncology, 2003
- Risk Factors for Relapse in Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: Results of the German Testicular Cancer Study Group TrialJournal of Clinical Oncology, 2003
- Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular CancerJournal of Clinical Oncology, 2003
- Cardiovascular Morbidity in Long-Term Survivors of Metastatic Testicular CancerJournal of Clinical Oncology, 2000
- Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular CancerJNCI: Journal of the National Cancer Institute, 1997
- Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report.Journal of Clinical Oncology, 1996
- Secondary neoplasms following treatment of malignant germ cell tumors.Journal of Clinical Oncology, 1993
- Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party.Journal of Clinical Oncology, 1992